BioCurex Announces Shareholder Update
01 mai 2009 09h00 HE
|
BioCurex, Inc.
RICHMOND, British Columbia, May 1, 2009 (GLOBE NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) wishes to communicate to its shareholders that certain note holders have agreed to grant the company an...
BioCurex Reports On Presentation of RECAF Results At the 'XII International Symposium On Biology and Clinical Usefulness of Tumor Markers' Held in Europe
19 févr. 2009 09h00 HE
|
BioCurex, Inc.
RICHMOND, British Columbia, Feb. 19, 2009 (GLOBE NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) today reported on its RECAF presentation at this international cancer congress held in Barcelona, Spain.
Four...
BioCurex Comments On Market Activity
03 juil. 2008 09h30 HE
|
BioCurex, Inc.
RICHMOND, British Columbia, July 3, 2008 (PRIME NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) is aware of the recent trading activity in the company's stock and notes that there has been no material change...
BioCurex Announces Plans for Direct Commercialization of Its ELISA RECAF Blood Tests for Cancer
12 juin 2008 09h20 HE
|
BioCurex, Inc.
RICHMOND, British Columbia, June 12, 2008 (PRIME NEWSWIRE) -- Following the completion of its successful testing on bladder, kidney, stomach and other types of cancer, BioCurex (OTCBB:BOCX) is pleased...
BioCurex Develops New Format for Its RECAF Cancer Blood Test; Results Confirm Its Accuracy
28 mai 2008 09h20 HE
|
BioCurex, Inc.
RICHMOND, British Columbia, May 28, 2008 (PRIME NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) today announced that it has developed an ELISA blood test using RECAF technology and reports results comparable...
European Patent Office Grants Patent for BioCurex's RECAF Blood Tests
25 mars 2008 21h15 HE
|
BioCurex, Inc.
RICHMOND, British Columbia, March 25, 2008 (PRIME NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) announced today that the European Patent Office (EPO) has granted the Company's patent claims for cancer...
BioCurex Announces Amendments to Licensing Agreement
20 mars 2008 20h09 HE
|
BioCurex, Inc.
RICHMOND, British Columbia, March 20, 2008 (PRIME NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) is pleased to announce that it has reached an agreement in principle to amend its licensing agreement, dated...
BioCurex Gains Second Major RECAF Licensing Agreement
10 janv. 2008 09h29 HE
|
BioCurex, Inc.
RICHMOND, British Columbia, Jan. 10, 2008 (PRIME NEWSWIRE) -- The licensing agreement for BioCurex's (OTCBB:BOCX) RECAF material and technology, just signed with Inverness Medical Innovations Inc.,...
BioCurex Licenses RECAF Technology to Inverness Medical Innovations
09 janv. 2008 09h29 HE
|
BioCurex, Inc.
RICHMOND, British Columbia and WALTHAM, Mass., Jan. 9, 2008 (PRIME NEWSWIRE) -- BioCurex (OTCBB:BOCX) and Inverness Medical Innovations (AMEX:IMA) have announced a licensing agreement for BioCurex's...
Photo Release -- Dr. Stewart Sell Wins ISOBM-Abbott Award
25 sept. 2007 16h05 HE
|
BioCurex, Inc.
RICHMOND, British Columbia, Sept. 25, 2007 (PRIME NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) has the pleasure to announce that Dr. Stewart Sell, a member of BioCurex's Scientific Advisory Board since...